Status:
COMPLETED
The Effect of Zinc Acetate Lozenges on the Rate of Recovery From the Common Cold
Lead Sponsor:
University of Helsinki
Collaborating Sponsors:
The University Pharmacy, Helsinki
Conditions:
Common Cold
Respiratory Tract Infections
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
A randomized parallel-group two arm superiority trial with an allocation ratio 1:1, both participants and investigators blinded. The zinc lozenge that will be used in the study is a commercial produc...
Eligibility Criteria
Inclusion
- ≥18 years, recollecting that they usually have had ≥1 colds per winter.
Exclusion
- pregnancy or lactation; chronic runny nose or chronic cough.
Key Trial Info
Start Date :
December 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 24 2018
Estimated Enrollment :
87 Patients enrolled
Trial Details
Trial ID
NCT03309995
Start Date
December 1 2017
End Date
September 24 2018
Last Update
February 5 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
City of Helsinki
Helsinki, Finland